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Tooth movement induced by orthodontic treatment can cause sequential reactions involving the
periodontal tissue and alveolar bone, resulting in the release of numerous substances from the
dental tissues and surrounding structures. To better understand the biological processes involved
in orthodontic treatment, improve treatment, and reduce adverse side effects, several of these
substances have been proposed as biomarkers. Potential biological markers can be collected from
different tissue samples, and suitable sampling is important to accurately reﬂect biological pro-
cesses. This paper covers the tissue changes that are involved during orthodontic tooth movement
such as at compression region (involving osteoblasts), tension region (involving osteoclasts), den-
tal root, and pulp tissues. Besides, the involvement of stem cells and their development towards
osteoblasts and osteoclasts during orthodontic treatment have also been explained. Several pos-
sible biomarkers representing these biological changes during speciﬁc phenomenon, that is, bone
remodelling (formation and resorption), inﬂammation, and root resorption have also been pro-
posed. The knowledge of these biomarkers could be used in accelerating orthodontic treatment.
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1. INTRODUCTION
The success of orthodontic treatment is inﬂuenced by a number of factors, including periodontal health,
oral hygiene, and orthodontic forces [1]. The development of new methods to accelerate orthodontic tooth
movement (OTM) has been sought by clinicians as a way to shorten treatment times, reduce adverse effects
such as pain, discomfort, dental caries, and periodontal diseases, and minimize iatrogenic damages such as
root resorption and the subsequent development of nonvital teeth.
Tooth movement induced by orthodontic force application is characterised by remodelling changes
in the dental and periodontal tissues [2]. Two interrelated processes involved in OTM are (1) deﬂection,
or bending, of the alveolar bone and (2) remodelling of the periodontal tissues, including the dental pulp,
periodontal ligament (PDL), alveolar bone, and gingiva. The applied force causes the compression of the
alveolar bone and the PDL on one side, while on the opposite side the PDL is stretched [3].
When exposed to varying degrees of magnitude, frequency, and duration of mechanical loading,
bone and adjacent periodontal tissues show extensive macroscopic and microscopic changes. Mechanical
loading also alters periodontal tissue vascularity and blood ﬂow, resulting in the local synthesis and
release of various molecules such as neurotransmitters, cytokines, growth factors, colony-stimulating
factors (cytokines that involved in maturing of various leucocyte, macrophage, and monocyte line), and
arachidonic acid metabolites. The released molecules evoke cellular responses in the various cell types in
and around teeth, providing a favourable microenvironment for tissue deposition or resorption [2]. Various
cell-signalling pathways are activated, which ultimately stimulate PDL turnover, as well as localised bone
resorption and bone deposition [4].
Orthodontic tooth movement consists of three phases: the initial phase, the lag phase, and the postlag
phase. The initial phase is characterised by immediate and rapid movement and occurs 24 hours to 48 hours
after the ﬁrst application of force to the tooth. This rate is largely attributed to the displacement of the tooth
in the PDL space. The lag phase lasts 20 to 30 days and shows relatively little to no tooth displacement.
This phase is marked by PDL hyalinisation in the region of compression. No subsequent tooth movement
occurs until the cells complete the removal of all of the necrotic tissues. The postlag phase follows the lag
phase, during which the rate of movement increases [2].
The sequence of events following OTM can be characterized using suitable biomarkers. A biomarker
is a substance that is measured and evaluated objectively as an indicator of normal biologic processes,
pathogenic processes, or pharmacologic responses to a therapeutic intervention [5]. In investigating
biomarkers,therate,amount,andactivityofthereleasedsubstancesnotonlyreﬂecttheactivityofindividual
cells but also indicate the metabolic activity in the involved tissues or organs [6].
A good biomarker demonstrates high speciﬁcity and sensitivity. Speciﬁc markers are prominent only
in OTM. Sensitive markers should have the ability to inform about the biological condition in terms of
periodontal tissue changes and their relationships with the particular phase of OTM. Knowledge of the
ongoing process can lead to proper mechanical loading and thus shorten the period of treatment, which can
aid in avoiding adverse effects associated with orthodontic treatment.
This paper will discuss the tissue changes that are involved during OTM such as at compression
region (involving osteoblasts), tension region (involving osteoclasts), and dental root and pulp tissues. The
involvement of stem cells and their development towards osteoblasts and osteoclasts during orthodontic
treatment also will be discussed in this paper. Several possible biomarkers representing these biological
changes during speciﬁc phenomenon, that is, bone remodelling (formation and resorption), inﬂammation,
and root resorption, have been identiﬁed. In this paper, we suggest several biomarkers that are involved
during OTM such as ALP (bone formation) and TRAP 5a (bone resorption) which both involved in bone
remodelling, LDH (inﬂammation), and DSPP (root resorption). The observation of these biomarkers can
potentially be observed using sampling from four different sampling procedures, that is, tissue (biopsy),
serum, GCF, and saliva. We propose that GCF and saliva are the best and practical sampling procedure
to observe the suggested biomarkers. The knowledge of these biomarkers can be used in determining the
precise force and duration that should be used for each tooth and ultimately produce optimal treatments
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with minimal side effects or accelerate the treatments. We conducted literature search by using key words
such as OTM, orthodontic treatment, orthodontic markers, and orthodontic in search engine. In addition,
we also manually search related literature at Universiti Kebangsaan Malaysia Library. Suitable papers and
important result of the paper will be discussed and cited.
2. TISSUE AND CELL CHANGES DURING ORTHODONTIC TOOTH MOVEMENT
Theearlyresponseofperiodontaltissuestomechanicalstressinvolvesseveralmetabolicchangesthatenable
tooth movement. A slight change in the thickness of the PDL occurred after 1 hour of orthodontic force
loading, while more signiﬁcant changes were seen after 6 hours [33]. The periodontal tissues primarily
affected by orthodontic forces can be divided histologically into two main regions: the compression region
and tension region. Other regions that are affected are the dental root and pulp.
2.1. Compression Region
The compression region is an area that is pressed by the orthodontic appliance in the direction of the force.
Compression results in the deformation of blood vessels and disarrangement of tissues surrounding teeth.
Subsequently, blood ﬂow and periodontal tissue changes may adapt to the compression force. Metabolic
changes can occur to the cells of the periodontal ligament as a result of hypoxia and decreased nutrient
levels.
In hypoxic conditions, cells will rely on anaerobic glycolysis. Many enzymes involved in an
anaerobic metabolism can be potential markers. Lactate dehydrogenase is an example of a molecule that
accumulates during anaerobic metabolism [34]. Cells that adapt via metabolic changes will continue to live
and cells that cannot adapt to the ischaemic condition will die [35]. The dead cell will lyse, releasing all of
its contents to the milieu and subsequently causing the activation of local inﬂammatory processes.
Mechanical forces often cause hyalinisation leading to necrosis in the PDL and lead to bone
resorption. Hyalinisation occurs as cell-free areas of the PDL, in which the normal tissue architecture
and staining characteristics of collagen in the processed histologic material have been lost. Distortions
in the normal periodontal ﬁbre arrangement were observed [36]. Numerous cell fragments (debris), areas
of degraded matrix interspersed between the intact collagen ﬁbrils [37], and, in some cases, pyknotic nuclei
were also present in hyalinisation areas [36]. In rat models, the onset of hyalinisation of the compressed
PDL was found after 24 hours of orthodontic force application. Macrophages are ultimately responsible for
removing the hyalinised tissues.
Alveolar bone resorption occurs at the compression areas during tooth movement. Bone resorption
occurs through osteoclastic activity by osteoclast thus creating cavity in bone known as lacunae that later
will be ﬁlled in by osteoblast cells to cover the cavity. Two processes involved in bone resorption are
the solubilisation of minerals and the degradation of the organ matrix, which mainly consists of type I
collagen. These processes are driven by proteolytic enzymes and, in particular, matrix metalloproteinases
and lysosomal cysteine proteinases [9].
According to the concept of tissue response after OTM, bone repair at the compression region only
occurs when the magnitude of the force decreases [38]. However, electron microscopy observations showed
that tissue repair and the formation of bone occur at the pressure areas even with the maintenance of the
orthodontic forces in humans [39, 40]. As soon as the osteoclasts become inactive and move away from
the bone surface, the compression areas display bone formation [37]. Bone remodelling markers may be
examined by measuring osteoclastic and osteoblastic activities at the compression regions during the early
phases of OTM.
2.2. Tension Region
In the tension region, new bone is formed as a result of forces applied by braces during orthodontic
treatment. Osteoblasts are differentiated from the local precursor cells, that is, mesenchymal stem cells.
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Mature osteoblasts form the osteoids and the mineralisation processes follow [10]. In addition, endothelial
nitric oxide synthase (eNOS) was shown to mediate the bone formation in the tension area [11], which in
turn suggests that eNOS could be useful markers for osteoblastic activity. Enzyme proﬁles have also been
investigated in relation to alveolar bone formation at tension sites. Another biochemical marker that may be
useful during osteoblastic activity is alkaline phosphatase (ALP) [41, 42].
2.3. Dental Root and Pulp
One adverse effect caused by orthodontic treatment is root resorption, which is a common iatrogenic
consequence in the ﬁeld of orthodontics [43] and may start during the early stages of orthodontic treatment
[44, 45]. Irreversible root resorption is caused by excessive forces or decreased resistance to normal forces.
Roots do not shorten naturally with age, unless forces overcompressthe PDL [44]. Some odontoclasts reside
in root resorption site indicating that odontoclasts play central roles in root [9]. Study on markers involved
during odontoclast activity indicates that they can be potential markers for root resorption activity.
Biomechanical treatment factors such as magnitude, duration, direction, and type of force (e.g.,
intermittent, interrupted, and continuous) can have an impact on root resorption [46]. In the PDL of heavily
applied orthodontic rat molars, foci of lymphocytic inﬁltration were observed, which reﬂects inﬂammatory
responses to applied orthodontic forces [15]. The discontinuation of or reductions in orthodontic forces can
stop root resorption and initiate the healing process in the cementum. Intermittent forces result in shorter
tooth movement distances, but they are also associated with less severe root resorption than with continuous
forces. However, the relationship between the amount of tooth movement and root resorption is less clear
[46], and other unknown factors may inﬂuence the extent and depth of the root resorption [43].
In rats, matrix metalloproteinase-1 (MMP-1) and cathepsin K are important in root resorption
during tooth movement because they degrade the collagenous bone matrix in a mode similar to bone
resorption [9]. MMP-1 mRNA was detected in ﬁbroblastic cells, cementoblasts, and osteoblasts but not in
odontoclasts or osteoclasts. Moreover, MMP-1 mRNA was highly expressed in some cementocytes located
near odontoclasts and in many osteocytes [9]. On the other hand, cathepsin K mRNA was expressed only
in odontoclasts and osteoclasts [9, 41, 42]. Other cathepsins such as cathepsin B, L, and S are expressed by
osteoclasts in low amounts [9]. These indicated that MMP-1 and cathepsins warrant further observation in
human as markers for tooth root resorption activity.
However, it is still difﬁcult to ﬁnd precise biomarkers for root resorption or nonvital teeth because
osteoclasts are also activated. Therefore, a conventional radiograph is still a cheap, effective, and important
way to monitor root resorption. However, it is not an adequate tool in the diagnosis of apical shortening,
lateral or cervical root gaps, enlargement of root canals, and external root radiolucencies in early stages.
It also has the limitation of being a 2-dimensional image [43, 47]. In contrast, computed tomography can
also be used to evaluate root resorption using a 3-dimensional approach [43]. However, the accuracy of this
approach in determining root resorption warrants further evaluation.
3. DEVELOPMENT OF DENTAL STEM CELLS DURING OTM
Stem cells are those with the ability to divide for indeﬁnite periods of time and with the ability to
differentiate into a variety of cell types. Stem cells can be divided into three categories: totipotent,
pluripotent, and multipotent cells (Figure 1)[ 48, 49]. Totipotent cells are the most primitive cells, followed
by pluripotent cells. The multipotent cell type is the most differentiated type of stem cell (Figure 1)[ 50].
Totipotent cells have the potential to differentiate into any type of cell in the body and are capable
of developing into a complete organism. After several cell division cycles, totipotent cells will develop into
pluripotent cells. Pluripotent cells are capable of dividing and differentiating into any type of cell, tissue, or
organ (Figure 1). However, these cells are not capable of developing into a complete organism. Multipotent
cells have more limited capacities than do pluripotent cells (Figure 1). Other types of primitive cells include
progenitor cells, which are able to differentiate into only one type of mature cell (Figure 1)[ 41, 51].
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FIGURE 1: Classiﬁcation of primitive cells. Stem cells are primitive cells that can be classiﬁed into three
types: totipotent, pluripotent, and multipotent. Each type of cell has distinguishable characteristics. The pro-
genitor cell is also a primitive cell, although this cell is the most differentiated cell among the primitive cells.
Most stem cells are isolated from bone marrow. However, stem cells can also be found in the
umbilical cord blood, peripheral blood, and teeth. Dental stem cells comprise an elusive population of
self-renewing cells that may have the potential to biologically replace lost or damaged teeth in humans
[52]. These cells consist of two types: epithelial stem cells and mesenchymal stem cells. Tooth formation
results from the interaction of epithelial and mesenchymal stem cells, where epithelial stem cells give rise
to ameloblasts and mesenchymal stem cells form odontoblasts, cementoblasts, osteoblasts, and ﬁbroblasts
of the periodontal ligament [53].
The “pressure-tension theory” associated with OTM states that the application of physiologic
force, including compressional and tensional changes to the periodontal ligament (PDL), will activate
mesenchymalstemcells.ThePDLprogenitorcellsthatexperienceforcewilldifferentiateintocompression-
associated osteoclasts and tension-associated osteoblasts, causing bone resorption and apposition,
respectively [7]. The multipotent mesenchymal stem cells begin their differentiation within hours of
orthodontic force application [7, 54].
3.1. Cells Involved during OTM
Osteoblasts and osteoclasts are two important cells that are involved in OTM [7]. As such, many studies
have focused on these cells during OTM. Osteoblast cells are involved in bone formation, which begins 40
to 48 hours after the application of orthodontic forces [7, 55]. Osteoblast differentiation starts with stem
cells that originated from the bone marrow that migrated into the blood vessels. Migration of mesenchymal
stem cells from blood vessel walls, or mesenchymal stem cell precursor activation and preosteoblast
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formation, occursabout10hoursaftertheapplicationofforce[7].Thissequenceofcellularactivitiesoccurs
during the development of the stem cell into osteoblast and osteoclast cells may be useful in determining
potential markers associated with OTM. Osteoclast cells are multinucleated cells which degrade and resorb
bone. Osteoclast cells which work together with osteoblast cells in bone remodelling are derived from
haematopoietic stem cells [42, 51, 56].
4. MARKERS FOR ORTHODONTIC TOOTH MOVEMENT
Applying orthodontic forces to teeth will ultimately result in movement. The main phenomena, both before
and after tooth movement, are alveolar bone remodelling, tissue inﬂammation, and root resorption. Each of
these events can potentially be detected using suitable markers.
4.1. Markers of Alveolar Bone Remodelling
Asorthodonticforcesareappliedtoteeth,thecompressionregionshowsanelevationinosteoclasticactivity.
Meanwhile, in the tension region, osteoblasts begin to proliferate and mineralise the extracellular matrix.
This orchestra results in alveolar bone remodelling [10].
Chemokines may contribute to differential bone remodelling in response to orthodontic forces
through the establishment of distinct microenvironments in the sites of both compression and tension [57].
The principal trigger for OTM is most likely the strain experienced by the PDL cells, bone-related cells,
and the extracellular matrix. This strain leads to changes in gene expression in the cells via interactions
between the cells and the extracellular matrix [4]. One of the examples are matrix metalloproteinases
(MMPs). MMPs break down the extracellular matrix and are important in bone remodelling. Compression
induces an increase in MMP-1 protein levels after 1 hour. However, the increase lasted for 2 hours and
subsequently disappeared. Tension led to signiﬁcantly increased levels of MMP-1 protein after just 1 hour
of force application and also subsequently disappeared [31].
MMP-2 protein was induced by compression and increased signiﬁcantly in a time-dependent fashion,
reaching a peak after 8 hours of force application. On the tension side, MMP-2 was signiﬁcantly increased
after 1 hour but gradually returned to basal levels within 8 hours [31]. This result indicates that MMP-2
could be used during very early stages of orthodontic treatment as a marker for active tooth movement.
4.1.1. Bone Formation Marker
Bone formation is primarily due to osteoblastic activities. Therefore, bone formation markers are usually
osteoblastic enzymes or byproducts of bone formation such as type I procollagen. Type I procollagen was
secreted by osteoblast cells.
The cleavages of procollagen will produce two types of procollagen, that is, procollagen type I C-
terminal propeptide (PICP) and procollagen type I N-terminal propeptide (PINP) that were proposed to be
measured as bone formation markers [58]. However, PICP and PINP are markers that can only indicate the
formation of type I collagen and not totally bone speciﬁc[ 58]. Therefore, other markers that speciﬁcally
activated during osteoblast differentiation or activity are needed.
Many genes are involved in osteoblast differentiation. The transcription factor (TF) Cbfa1 (or Runx-
2) is the earliest expressed and the most speciﬁc bone formation marker and helps to control osteoblast
differentiation. Cbfa1-binding site also present at the regulatory sites of most genes that is involved in
regulating bone matrix secretion by mature osteoblast [7]. On the other hand, Osterix, a TF, is involved
in bone formation and induces mature osteoblasts to express osteocalcin. In contrast, the expression of
osteocalcin will inhibit osteoblast differentiation [7, 59]. Indicate Cbfa1 and Osterix as potential markers
for early and late osteoblastic activity while osteocalcin as terminal osteoblast differentiation marker.
In addition, bone morphogenetic proteins (BMPs), transforming growth factor-beta (TGF-β) proteins
and growth-factor- (GFs) associated internal signalling molecules are other bone-forming genes that encode
proteins for GFs [7]. BMPs that bind to surface receptors on progenitor and mature osteoblasts can trigger
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a signalling pathway that promotes osteoprogenitor cell differentiation and the upregulation of osteoblast
activity. The expression of Cbfa1 also can be induced by BMPs.
Bone formation can also be promoted by GFs via their interaction with speciﬁc surface receptors
on osteoblasts, thereby stimulating insulin-like GF-1. Insulin-like GF-1 is a primary mediator of the effects
of growth hormones that have growth-promoting effects on bone, in addition to regulate cell growth and
development. Other studies have found that Msx1 and Msx2 are potential regulators of bone formation. The
Msx1, protein is known as a critical modulator of bone development and remodelling, and Msx2 is an alter-
native regulator protein of Cbfa1 expression in bone formation during OTM. Therefore, Cbfa1 (or Runx-2),
osterix, osteocalcin, BMPs, TGF-β, GF-associated internal signalling, insulin-like GF-1, Msx1 and Msx2
can be used as potential biomarkers during the development of stem cells into osteoblasts during OTM.
Mechanical forces in orthodontic treatment cause the physical distortion of PDL and alveolar bone
cells. They can also trigger a multilevel cascade of signal transduction pathways, such as the prostaglandin
E2 (PGE2) pathway, that initiate structural and functional changes in extracellular, cell membrane, and
cytoskeletal proteins [7]. Subsequent changes in cytoskeletal protein structure and function lead to the
creation of new cells and bone matrix formation [7, 60, 61].
The relationship between ALP and mineralisation has been the subject of many studies since
Robinson’s ﬁrst discussion of the enzyme in 1923 [62]. Although extensive knowledge has been gained,
the exact role of ALP in mineral formation remains to be established. Several investigations have
produced consistent ﬁndings with regard to the localisation of the enzyme in mineralising tissues. Enzyme
cytochemical studies have repeatedly demonstratde that ALP activity is closely associated with cell and
matrix vesicle membranes in cartilage calciﬁcation, intramembranous osteogenesis, and newly forming
dentine [62]. ALP activity was detected in the osteoid areas of new bone formation but not in the calciﬁed
bone matrix. The cells that showed high ALP activities were preosteoblasts, osteoblasts [41, 42, 51],
lining zones, newly embedded osteocytes, endosteal cells, and subperiosteal cells [63]. In conjunction with
bone formation induced by orthodontic forces, increased levels of ALP were detected in human gingival
crevicular ﬂuid (GCF) collected from orthodontically treated human samples. Therefore, they might have
biological activities in the early stages of tooth movement [17, 18].
4.1.2. Bone Resorption Marker
Osteoclastic cells that are involved in bone resorption are specialised multinucleated giant cells that
originate from haematopoietic stem cells [42, 64]. The earliest bone resorption marker is the interleukin-
1 beta (IL-1β)[ 7]. PGE2, interleukin-6 (IL-6), and other inﬂammatory cytokines can also facilitate
osteoclastic bone resorption processes [7, 65]. These proteins regulate osteoclastic activity through
activation of the nuclear factor kappa B (RANK) and of the nuclear factor kappa B ligand (RANKL).
Osteoblastic cells also control osteoclastic processes by synthesizing RANKL to promote more osteoclastic
differentiation [7, 66].
Signal induction between osteoblasts with surface expression of RANKL and osteoclastic precursors
carrying the receptor RANK induces osteoclastic formation and activation [67, 68]. A study by Oshiro et
al. [69] has demonstrated changes in RANK, RANKL, and osteoprotegerin (OPG) in the tooth-supporting
tissues during OTM, where RANKL stimulation and OPG inhibition are involved in osteoclastogenesis
[67, 70]. Compressive forces upregulate RANKL through the PGE2 pathway and thereby support
osteoclastogenesis [67, 70].
The transfer of the local RANKL gene to the periodontal tissue using a Hemagglutinating Virus of
Japan(HVJ) envelopevector wasreported to accelerateOTM in 6-week-old male Wistar rats. The activation
of transferred RANKL gene in the periodontal tissue indicates that RANKL is involved during active OTM
especially in periodontal area [71]. On the other hand, the activation of the OPG gene, also through gene
transfer to periodontal tissues, managed to neutralize RANKL activity and hence inhibits osteoclastogenesis
and eventually OTM. There is an indication that the activation of the OPG gene inhibits the OTM process
[67]. Furthermore, several cases have demonstrated that increases in RANKL and decreases in OPG can be
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observed during severe orthodontic root resorption [67, 72]. Therefore, we suggest that root resorptive pro-
cesses need speciﬁc biomarkers other than RANKL or OPG in order to apply optimum force during OTM.
The enzyme assay of acid phosphatase activity in saliva was also introduced as a method used to
measure biomarkers of OTM. On the basis of the enzymatic proﬁle activity of lactate dehydrogenase,
tartrate resistant acid phosphatase (TRAP) and ALP in mixed saliva, Zainal Arifﬁne ta l .[ 19] suggested
the reactivation of orthodontic braces from 30 days to 25 days so that the treatment course will be decreased
by approximately 17%.
Other biomarkers of early OTM were investigated in a rat model using a split-mouth design at 3
and 24 hours after appliance insertion. The spatial expression patterns of KI-67, RANKL, and Runx2
during OTMwere mappedbyusingimmunohistochemical staining. TheexpressionofKI-67, a proliferation
marker, and RANKL, a molecule associated with osteoclastic differentiation, increased in the compression
sites of the periodontal ligament subjected to 3 hours of force. On the other hand, there were increased
expression of KI-67 and Runx2, both markers of osteoblastic precursors, in the areas of tension after 24
hours of force. The early expression of RANKL indicates that cells are involved in osteoclastic precursor
signalling at this early stage. In addition, decreased KI-67 expression found near the midpoint of the tooth
root is believed to represent the centre of rotation, providing a molecular means of visualising mechanical
loading patterns and runt-related transcription factor 2 (Runx2) [12].
The potential of TRAP as a biomarker of bone resorption has been long recognised [73]. TRAP
activity was very strong in in vitro osteoclast cultures. Reﬁnement of the activity assay to primarily measure
TRAP 5b at a pH level of 6.1 was suggested for investigation of osteoclastic activity and bone resorption
rates [73]. This will differentiate between TRAP 5a that have optimum pH at 5.2 compared to TRAP 5b
with optimum pH at around 6, hence TRAP5b activity can be precisely measured. However, no proper
investigation has yet been conducted involving TRAP 5b assayed at a pH level of 6.1.
Nitric oxide (NO) is an important regulator of bone responses to mechanical stress and is produced
through the activity of constitutive endothelial nitric oxide synthase (eNOS) or inducible nitric oxide
synthase (iNOS). NO mediates adaptive bone formation, protects osteocytes against apoptosis and mediates
osteoclastic activity. High levels of NO reduce osteoclastic activity, while the inhibition of NO production
increases osteoclastogenesis and osteoclastic activity [11]. Using a rat model and immunohistochemistry
techniques, Tan et al. [11] showed that the number of endothelial-nitric-oxide-synthase- (eNOS-) positive
osteocyteswassigniﬁcantly higherat both 24and48hours thanat baselineduring tooth movement. After 48
hours, however, the number decreased to baseline levels. The number of inducible-nitric-oxide-synthase-
(iNOS-) positive osteocytes was signiﬁcantly higher than baseline levels between 6 and 48 hours, as the
number increased 3.0- to 4.1-fold. Subsequently, the number decreased to baseline levels. As such, iNOS
mediates inﬂammation-induced bone resorption in areas of compression [11].
Osteocalcin is the most abundant noncollagenous matrix protein found in bone. It is expressed by
highly differentiated osteoblasts and is incorporated into the bony matrix. Smaller osteocalcin fragments
are thought to be a degradation products of bone matrix, which suggests its potential as a bone resorption
marker [58].
4.2. Markers of Inﬂammatory Processes
The host response to orthodontic forces has been described as aseptic and transitory inﬂammation. Among
the substances investigated are lactate dehydrogenase (LDH) and aspartate aminotransferase (AST), which
are inﬂammatory biomarkers found outside cells during necrosis. Increased levels of lactate dehydrogenase
[29, 30] and aspartate aminotransferase [20–22] were detected in human GCF samples obtained during
OTM.However,increasedlevelsoflactatedehydrogenaseinwholesalivacanbeassociatedwithperiodontal
disease as well, especially with the presence of calculus and periodontal pockets greater than 5mm [74].
Aspartate aminotransferase is also found in periodontitis [75, 76].
Cathepsin B, an intracellular lysosomal cysteine proteinase, can degrade extracellular components
including collagen and cause protein turnover in the lysosomal system. It is also known to play an important
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TABLE 1: Markers involved in orthodontic tooth movement collected from dental tissues (alveolar bone,
periodontium and pulp).
Marker Function Sample Method Sources
Bone morphogenetic
proteins (BMPs)
Bone formation Rat pulp tissue Quantitative RT-PCR [7, 8]
Cathepsin K
Root and bone resorption;
expressed in odontoclasts and
osteoclasts
Rat maxillary bone Hybridization [9]
Endothelin-1,endothelin
receptors (ETA and ETB)
Stimulates the proliferation of
osteoblasts; their
downregulation indicates the
end of stage 2 and start of
stage 3
Rat alveolar bone RT-PCR [10]
Endothelial nitric oxide
synthase (eNOS)
Mediates bone formation in
the tension area
Rat maxilla tissue Immunohistochemistry [11]
Inducible nitric oxide
synthase (iNOS)
Mediates
inﬂammation-induced bone
resorption in the compression
area.
Rat maxilla tissue Immunohistochemistry [11]
Ki-67 Proliferation Rat maxilla Immunohistochemistry [12]
Muscle segment
homeobox 1 (Msx1)
Regulator for bone formation
Human alveolar
mucoperiosteum
Quantitative RT-PCR,
Immunohistochemistry
[7, 13]
Muscle segment
homeobox 2 (Msx2)
Regulator for bone formation
Mouse periodontal
ligament tissue
Histopathological,
Immunohistochemistry
[7, 14]
Osteoprotegerin (OPG)
Osteoclastogenesis-inhibitory
factor
Rat mandible RT-PCR [15]
Receptor activator of
nuclear factor kappa B
ligand (RANKL)
Osteoclastic differentiation Rat maxilla Immunohistochemistry [12]
Runx2 Osteoblast precursor Rat maxilla Immunohistochemistry [12]
Transforming Growth
Factor-B (TGF-B)
Bone formation
Rat alveolodental
connective tissue
Immunohistochemistry [7]
role in the initiation and perpetuation of inﬂammatory processes. The accumulation of cathepsin B in GCF
has been shown to increase with OTM. Cathepsin B was increased around osteoclasts; it played a role in
the decomposition of exposed collagen ﬁbres and collagen degradation byproducts [23].
Myeloperoxidase (MPO) is an enzyme found in polymorphonuclear neutrophil (PMN) granules and
can be used to estimate the number of PMN granules in tissues. Mean MPO activity was increased in both
the GCF and saliva of orthodontic patients at 2 hours after appliance activation. MPO might be a good
biomarker to assess inﬂammation in orthodontic movement [32].
4.3. Markers of Root Resorption
Root resorption is either a physiological or pathological condition associated with tooth structure loss and is
caused by osteoclastic cells. Orthodontic treatment invariably results in permanent root resorption [47]. The
resorptive process starts just below the gingival epithelial attachment of the tooth, extending apically and/or
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TABLE 2: Markers involved in orthodontic tooth movement collected from serum.
Marker Function Sample Method Sources
N-terminal propeptide of type 1
procollagen
Bone turnover
Serum of
premenopausal
woman
ELISA [16]
Osteocalcin Bone turnover
Serum of
premenopausal
woman
ELISA [16]
C-telopeptide of type 1 collagen
(CTX)
Bone turnover
Serum of
premenopausal
woman
ELISA [16]
Insulin-like growth factor-1
Decreases collagen
degradation, increases bone
matrix deposition, and
recruits osteoblasts
Serum of
premenopausal
woman
ELISA [16]
coronally along the root dentin. Usually, even in advanced cases, there is no pulpal involvement because
of the protective nature of the predentine layer, which explains the asymptomatic nature of this type of
resorption. However, the very thin dentin layer that remains is at risk of perforation during the removal of
the existing granulation tissue and may necessitate root canal treatment. The often delayed nature of the
resorptive process is even more difﬁcult to explain. According to one theory, there is a decrease in the ratio
of organic to inorganic cementum cells [77].
Dentine consists of noncollagenous proteins such as DMP1 (dentine matrix protein 1), dentine
phosphoprotein (DPP), and dentine sialoprotein (DSP). DPP and DSP are products of mRNA transcription
and are portions of one expressed protein known as dentine sialophosphoprotein (DSPP). Examination of
patients undergoing active orthodontic treatment showed elevated levels of DPP relative to the control group
[25]. Kereshanan et al. [26] reported the potential for measuring dentine sialoprotein (DSP) in GCF as a
biomarker to monitor root resorption. GCF was collected from 20 patients undergoing treatment with ﬁxed
appliances at two time points, immediately prior to orthodontic intervention and 12 weeks following the
commencement of ﬁxed appliance therapy. GCF samples were analysed for DSP using an immunoassay
and the levels were semiquantiﬁed using an image analysis. Results showed that DSP was raised at sites
that were undergoing physiological resorption compared with the nonresorbing controls. Notably, however,
DSP was detected in some of the control samples. Dentine is likely to be the major source for DSP in GCF,
although alternative origins such as bone and cementum are possible.
The peripheral nervous system in the tooth pulp and periodontium contributes to the development
of both acute and chronic inﬂammatory processes via the release of substance P (SP). SP stimulated the
production of IL-1β,I L - 6 ,a n dT N F - α in vitro in human dental pulp ﬁbroblasts with severe orthodontic root
resorption [72].
5. CONCLUSION
Many papers have proposed certain substances as biomarkers of OTM. There is progress in the development
of biomarkers to better understand the ongoing biological processes involved with OTM. On the basis
of sequential reactions and released substances, numerous substances have been proposed as biomarkers.
Knowledge regarding stem cell development and osteoblastic and osteoclastic activity involved in bone
formation and resorption, respectively, can be useful in the identiﬁcation of potential OTM biomarkers as
well. There is also the question of how to obtain useful samples by ethical and noninvasive methods. To this
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TABLE 3: Markers involved in orthodontic tooth movement collected from GCF and saliva.
Marker Function Sample Method Sources
Alkaline phosphatase
(ALP)
Bone formation Human saliva and GCF Enzyme assay [17–19]
Aspartate
aminotransferase
(AST)
Tissue damage and
inﬂammatory process
Human GCF Enzyme assay [20–22]
Cathepsin B
Resolution organic matrix; bone
resorption
Human GCF
Fluorometry,
enzyme assay,
Western blot
[23, 24]
Dentine
phosphoprotein (DPP)
Root resorption Human GCF ELISA [25]
Dentine sialoprotein
(DSP)
Root resorption Human GCF Western blot [26]
Activity index of
Interleukin-1β and
interleukin-1 receptor
antagonist
IL-1β is potent for bone
resorption and the inhibition of
bone formation
Human GCF ELISA [27]
Interleukin-2 (IL-2)
B-cell activation, stimulates
macrophages and NK Cell,
T-cell proliferation, osteoclastic
activity
Human GCF Immunoassay [28]
Interleukin-6 (IL-6)
Stimulates osteoclast formation
and bone resorbing activity of
preformed osteoclasts
Human GCF Immunoassay [28]
Interleukin-8 (IL-8)
Recruitment and activation of
neutrophils
Human GCF Immunoassay [28]
Lactate dehydrogenase
(LDH)
For monitoring periodontal
metabolic changes, index of
tissue destruction
Human saliva and GCF Enzyme assay
[19, 29,
30]
Matrix
metalloproteinase-1
(MMP-1)
PDL remodelling during initial
tooth movement
Human GCF Western blot [31]
Matrix
metalloproteinase-2
(MMP-2)
PDL remodelling during initial
tooth movement
Human GCF Western blot [31]
Myeloperoxidase
To asses inﬂammation in
orthodontic movement
Human GCF Enzyme assay [32]
Tartrate resistant acid
phosphatase (TRAP)
Osteoclastic differentiation Human GCF Enzyme assay [19]
end, saliva and GCF are two common, noninvasive methods of collecting samples associated with OTM.
A summary of all currently known potential markers for OTM is shown in Tables 1, 2,a n d3. The clinical
use of these biomarkers is still an issue. Therefore, the determination of suitable OTM process biomarkers
remains a challenging task. In this paper, we proposed one potential marker for each phase during OTM, that
is, ALP (bone formation), TRAP5a (bone resorption), LDH (inﬂammation), and DSPP (root resorption).
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